News

The Malaysian Reserve19h
Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer
Atossa’s progress reflects the strong strategic momentum promised in the March 11, 2025 announcement of a metastatic focus; momentum that aligns well with FDA expectations and regulatory standards, ...
The Observer on MSN3d
Biotech start-ups on quest for ‘holy grail’ anti-ageing drug
LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
FDA vaccines head, chief medical officer Vinay Prasad departs agency
Vinay Prasad leaves FDA apparently due to backlash from the agency's handling of potential deaths related to Sarepta's ...
US FDA's chief medical and science officer Prasad departs agency
Vinay Prasad, the U.S. Food and Drug Administration's chief medical and science officer, has left the health regulator, the U ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
STAT22h
How the FDA can score quick wins on transparency
Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...